Popular Articles

$10 Million European Community Water And Sanitation Project Underway In Iraq; UNICEF Relocates Country Office To Baghdad
- A $10 million project funded by the European Community to improve Iraq"s water and sanitation services is underway. Implemented by UNICEF in collaboration with the Ministry of Municipalities and Public Works and the Ministry of Municipalities in Kurdistan, the project will increase the government"s provision of services as well as strengthen their capacity to manage and develop Iraq"s water and sanitation sector.

Diabetes UK Launches Its National Measure Up Roadshows
Diabetes UK launches its national Measure Up Roadshow today to tackle the diabetes epidemic, as it reveals that more than 1.7 million people in the UK could have avoided developing Type 2 diabetes.
News of the day
Digital Medicine: Health Care In The Internet Era
With more than $19 billion in new spending planned for health information technology, the Obama administration is taking serious steps toward modernizing the U.S. health care system. Implementing health IT can reduce both costs and errors, but it requires extensive information infrastructure upgrades. Few hospitals, clinics or private practices have the funds to pay for new technology. The new Brookings Institution Press book Digital Medicine: Health Care in the Internet Era investigates the factors affecting digital technology"s ability to remake health care.
Public Health

In A "David Against Goliath" Move, SKIN.NY(R), Takes On Boots For Misleading Public By Making False Claims About No.7 Protect & Perfect Products, UK

Cult skincare brand SKIN.NY(R) have issued legal proceedings against beauty giant, Boots the Chemist, for misleading the public. In a recent blaze of publicity, Boots the Chemist claimed that their much-lauded Boots No.7 Protect and Perfect was the first anti-wrinkle cream to be proven to be effective in clinical trials. This is untrue. In fact, SKIN.NY Radical Restructure Complex(R) containing QAL-100(R) was the first complex skin cream with proven clinical trials published in the BJD over 6 years earlier in October 2003. SKIN.NY(R) also gives faster, broader skincare results. SKIN.NY(R) achieves more in three months than Boots No.7 does in six - SKIN.NY(R) delivers an additional 10% in wrinkle reduction. In fact the "inactive" control cream used in the SKIN.NY(R) study was as effective in 3 months as the Boots Serum was in a year. This also makes SKIN.NY(R) more cost-effective - three month"s supply of SKIN.NY(R) costs GBP99.00 whereas six month"s of Boots No.7 is GBP197.50. The facts speak for themselves - the trials SKIN.NY 3 month"s double blind clinical trials with product used twice daily. Trial data published in the British Journal of Dermatology (BJD) February 2003. Boots No.7 6 month"s double-blind clinical trials, 6 month"s open trials, product used once daily. Trial data published in The British Journal of Dermatology (BJD) April 2009. What did they test for SKIN.NY fine lines (measured with objective method laser profilometery, and also with photographic assessment, clinical assessment and self evaluation), deep lines, pore size, pigmentation, bags under the eyes, skin colour, telangiectasia (small dilated blood vessels), visible dryness, scaling, elasticity, tactile roughness Boots No.7 fine lines/wrinkles, (only clinical assessment, no objective clinical measurement was used) dyspigmentation, overall clinical grade of photo-ageing, tactile roughness The results SKIN.NY Facial wrinkles at 3 months - P SKIN.NY


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):